Literature DB >> 31249790

Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078].

Gustav Johansson1,2,3, Daniel Andersson1, Stefan Filges1, Junrui Li1, Andreas Muth4, Tony E Godfrey5, Anders Ståhlberg1,2,6.   

Abstract

[This corrects the article DOI: 10.1016/j.bdq.2018.12.003.].

Entities:  

Year:  2019        PMID： 31249790      PMCID： PMC6587021          DOI： 10.1016/j.bdq.2019.100091

Source DB:  PubMed          Journal:  Biomol Detect Quantif


  2 in total

1.  Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA.

Authors:  Mohammad Amin Kerachian; Marjan Azghandi; Sina Mozaffari-Jovin; Alain R Thierry
Journal:  Clin Epigenetics       Date:  2021-10-18       Impact factor: 6.551

2.  Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.

Authors:  Semini Sumanasuriya; George Seed; Harry Parr; Rossitza Christova; Lorna Pope; Claudia Bertan; Diletta Bianchini; Pasquale Rescigno; Ines Figueiredo; Jane Goodall; Gemma Fowler; Penelope Flohr; Niven Mehra; Antje Neeb; Jan Rekowski; Mario Eisenberger; Oliver Sartor; Stéphane Oudard; Christine Geffriaud-Ricouard; Ayse Ozatilgan; Mustapha Chadjaa; Sandrine Macé; Chris Lord; Joe Baxter; Stephen Pettitt; Maryou Lambros; Adam Sharp; Joaquin Mateo; Suzanne Carreira; Wei Yuan; Johann S de Bono
Journal:  Eur Urol       Date:  2021-06-05       Impact factor: 20.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.